Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
ARCK was delisted on the 12th of January, 2023.
59 hedge funds and large institutions have $139M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
11% more funds holding
Funds holding: 53 → 59 (+6)
8% more capital invested
Capital invested by funds: $129M → $139M (+$10.5M)
5.87% more ownership
Funds ownership: 74.66% → 80.53% (+5.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$11.1M |
| 2 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$3.06M |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$2.51M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$2.14M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$11.7M |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$2.51M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$753K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$113K |
ARCK Hedge Fund Activity: Q2 2022 in Review
59 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q2 2022, worth a combined $139M — up 8.2% from $129M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ARCK positions and 4 closed out — a net gain of 6 holders — while 15 added to existing stakes and 6 trimmed.
The largest buyer was Cantor Fitzgerald, adding an estimated $11.1M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $11.7M sold.
- 59 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q2 2022, up from 53 in Q1 2022.
- Funds reported $139M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q2 2022, up 8.2% quarter-over-quarter.
- 10 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q2 2022 and 4 closed out, a net change of +6 holders.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q2 2022 was Cantor Fitzgerald, an estimated $11.1M added.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q2 2022 was Beryl Capital Management, an estimated $11.7M sold.
Based on aggregated 13F filings for Q2 2022.